{
  "ticker": "ROIV",
  "company_name": "Roivant Sciences Ltd.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04351243",
      "title": "A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "COVID-19",
      "start_date": "2020-04-15",
      "completion_date": "2021-04-01",
      "enrollment": 0,
      "sponsor": "Kinevant Sciences GmbH"
    },
    {
      "nct_id": "NCT02611921",
      "title": "Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Autism Spectrum Disorder",
      "start_date": "2015-12-22",
      "completion_date": "2018-05-07",
      "enrollment": 0,
      "sponsor": "Children's Hospital Medical Center, Cincinnati"
    },
    {
      "nct_id": "NCT07188844",
      "title": "An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE2",
      "condition": "Chronic Inflammatory Demyelinating Polyneuropathy",
      "start_date": "2025-08-28",
      "completion_date": "2028-11",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    },
    {
      "nct_id": "NCT07018323",
      "title": "A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Graves' Disease",
      "start_date": "2025-06-19",
      "completion_date": "2027-05",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    },
    {
      "nct_id": "NCT05403541",
      "title": "Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Generalized Myasthenia Gravis",
      "start_date": "2022-06-27",
      "completion_date": "2025-04",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    },
    {
      "nct_id": "NCT05907668",
      "title": "A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Graves Disease",
      "start_date": "2023-05-15",
      "completion_date": "2025-07",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    },
    {
      "nct_id": "NCT06727604",
      "title": "A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Graves' Disease",
      "start_date": "2024-12-17",
      "completion_date": "2028-06",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    },
    {
      "nct_id": "NCT06754462",
      "title": "A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2025-01-10",
      "completion_date": "2027-09",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    },
    {
      "nct_id": "NCT03938545",
      "title": "ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Graves' Ophthalmopathy (GO)",
      "start_date": "2019-07-23",
      "completion_date": "2021-04-15",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    },
    {
      "nct_id": "NCT05581199",
      "title": "To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Chronic Inflammatory Demyelinating Polyneuropathy",
      "start_date": "2022-12-15",
      "completion_date": "2027-01",
      "enrollment": 0,
      "sponsor": "Immunovant Sciences GmbH"
    }
  ],
  "summary": {
    "total_trials": 44,
    "by_phase": {
      "PHASE2": 22,
      "PHASE1": 5,
      "PHASE3": 13,
      "": 1,
      "NA": 1,
      "PHASE4": 1,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 21,
      "ENROLLING_BY_INVITATION": 2,
      "RECRUITING": 9,
      "ACTIVE_NOT_RECRUITING": 5,
      "TERMINATED": 4,
      "NOT_YET_RECRUITING": 1,
      "WITHDRAWN": 1,
      "UNKNOWN": 1
    },
    "active_trials": 16,
    "completed_trials": 21,
    "conditions": [
      "Atopic Dermatitis",
      "Autism Spectrum Disorder",
      "COVID-19",
      "Chronic Inflammatory Demyelinating Polyneuropathy",
      "Endometriosis",
      "Endometriosis Related Pain",
      "Generalized Myasthenia Gravis",
      "Graves Disease",
      "Graves' Disease",
      "Graves' Ophthalmopathy",
      "Graves' Ophthalmopathy (GO)",
      "Healthy",
      "Heavy Menstrual Bleeding, Uterine Fibroid",
      "ICD10 Code L40.9 for Psoriasis",
      "Inflammation, Rheumatic Diseases",
      "Metrorrhagia, Pelvic Pain, Menorrhagia, Leiomyoma",
      "Myasthenia Gravis",
      "Primary Sj\u00f6gren's Syndrome",
      "Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8",
      "Prostate Cancer",
      "Prostate Cancer, Prostatic Neoplasms",
      "Rheumatoid Arthritis",
      "Sarcoidosis, Cardiac",
      "Sarcoidosis, Pulmonary",
      "Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus",
      "Thyroid Eye Disease",
      "Uterine Fibroid, Endometriosis",
      "Uterine Leiomyoma, Uterine Fibroids",
      "Vitiligo",
      "Warm Autoimmune Hemolytic Anemia"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:37.544173",
    "search_query": "Roivant Sciences Ltd.",
    "url": "https://clinicaltrials.gov/search?term=Roivant+Sciences+Ltd."
  }
}